In a dramatic one-year rise, Wisconsin surpassed the $100 million level in annual angel capital investments in 2006, according to a new report by NorthStar Economics. Investment experts believe that bodes well for the state's future ability to attract later-stage venture capital and provide technology...
The United States is still a dominant player in global biotech sales, R&D, publicly traded companies, and other parameters, but the rest of the world is catching up. In this edition of Yer Biotech Blues, columnist Michael Rosen outlines this and other findings from the...
The Wisconsin Alumni Research Foundation has filed a response refuting the U.S. Patent and Trademark Office's rejection of its human embryonic stem cell patents. WARF questioned the relevancy of patents and publications used to uphold the challenge to its stem cell patents. ...
Researchers studying the pattern of financing for women-owned businesses in the venture capital industry, where women receive only a small fraction of overall investment dollars, have found a similar pattern in the angel capital market. Their findings are consistent with other studies and the anecdotal...
Beyond equity financing, early-stage technology and biotechnology businesses may still have a need for other forms of financing. In this 11th edition of Early Stage, Madison attorney Joe Boucher begins to run through the various business borrowing options....
Most U.S. companies seem to have focused their growth efforts on China and India, but columnist Michael Rosen wants to remind them about Brazil. Rosen was dazzled by what he saw during a recent visit to Sao Paulo, and in this edition of Yer Biotech...
Companies in western Wisconsin and the Twin Cities will combine to develop bio-device products and capitalize on opportunities in the rapidly growing orthobiologics market. BioE, a St. Paul biomedical firm that is trying to impact medicine via cord blood-derived stem cells, and Phillips Plastics, which...
Although Wisconsin is not a one-trick pony when it comes to scientific discovery, the state's leadership in stem cell research gets most of the attention. In this edition of Inside Wisconsin, columnist Tom Still notes how Wisconsin received attention at the recent BIO convention for...
In an effort to strengthen its role in the fields of stem cell research and regenerative medicine, the University of Wisconsin-Madison will establish a new Stem Cell and Regenerative Medicine Center. The center will serve as a focal point for stem-cell research being conducted across...
They come from all corners of the state, armed with business plans that might just win any of them at least $50,000 in first place cash and services. They are the finalists in the fourth annual Governor's Business Plan Contest, and the winner will be...